Colonoscopy surveillance after colorectal cancer surgery: meta-analysis.
Joni Panula, Kalle E Hokkanen, Toni T Seppälä
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis examined randomized trials comparing follow-up protocols with versus without colonoscopy within 5 years after colorectal cancer surgery. Five trials involving 2337 patients were included. Colonoscopy was associated with more asymptomatic recurrence detection (RR 2.38; 95% c.i. 1.53 to 3.69) and more curative-intent reoperations (RR 1.66; 95% c.i. 1.16 to 2.37), but not improved survival (hazard ratio 0.92; 95% c.i. 0.77 to 1.11). The authors concluded that current randomized evidence does not clearly show a survival benefit.
Key findings
- Colonoscopy surveillance was associated with more asymptomatic recurrence detection (RR 2.38; 95% c.i. 1.53 to 3.69).
- Curative-intent reoperations were more frequent with colonoscopy (RR 1.66; 95% c.i. 1.16 to 2.37), without improved survival (hazard ratio 0.92; 95% c.i. 0.77 to 1.11).
- The number needed to scope to detect one recurrence was 159 (95% c.i. 101 to 267); estimated cost per colonoscopy-detected recurrence was €104 100 (95% c.i. €66 200 to 174 900).
Why it matters
Earlier detection and additional curative-intent surgery are potential benefits of postoperative colonoscopy, but this analysis did not find a corresponding survival improvement. The findings help distinguish detection and reoperation outcomes from demonstrated patient benefit, while highlighting uncertainty about colonoscopy’s independent contribution within multimodal follow-up.
What to keep in mind
All trials used additional surveillance modalities, creating a high risk of bias for estimating colonoscopy’s independent effect. Four of the five trials enrolled patients between 1983 and 1994, before subsequent advances in colorectal cancer treatment.